Hypoxia, a condition of severe oxygen shortage, induces a transcriptional response that is important for both normal embryonic development and the growth of tumors. In this issue, Cheng et al. (2007) describe how the stability of the major transcriptional regulator of the hypoxic response, HIF1α, is modulated by the interplay between the ubiquitin and the SUMO conjugation systems.
Posttranslational modifications of proteins by members of the ubiquitin family can modulate the properties of proteins in various ways by affecting their activity, stability, or interactions with other cellular factors. Ubiquitin itself is best known as a degradation signal when attached to its protein targets as a polymeric chain that is recognized by the 26S proteasome. The small ubiquitin-like modifier SUMO most frequently appears to alter protein-protein interactions. Although the ubiquitin and SUMO systems rely on independent enzymes for conjugation and removal, they are not blind to each other's actions, in fact, an intriguing number of proteins are targeted by both modifiers. In the case of the NF-κB inhibitor IκBα and the protein huntingtin, ubiquitin targets the substrate for degradation, whereas SUMO exerts a stabilizing effect. However, in most cases the relationship between ubiquitin and SUMO is more complex (Ulrich, 2005) . Therefore it is crucial to identify the physiological signals that trigger each modification for a given protein. In this issue of Cell, Cheng et al. (2007) provide insight into the interplay between ubiquitin and SUMO in the cellular response to hypoxia, a potentially dangerous condition of reduced oxygen concentration that requires a drastic adaptation of cellular metabolism .
Hypoxic conditions, found in tumors as well as during normal embryogenesis, activate a transcriptional response that promotes vascular development and the formation of red blood cells (erythropoiesis). The master transcriptional regulator of oxygen-controlled gene expression is the hypoxia-inducible factor HIF. HIF consists of two subunits, and the activity and stability of the α subunit (HIF1α) is subject to intricate regulation. At physiological levels of oxygen, HIF1α is hydroxylated by oxygen-dependent prolyl hydroxylases, allowing an interaction with the ubiquitin ligase VHL. This interaction leads to rapid polyubiquitination and proteasomal degradation of HIF1α. The α subunit of the hypoxia-inducible transcription factor (HIF) undergoes multiple posttranslational modifications. Under normoxic conditions, the dioxygenase FIH (factor-inhibiting HIF1) hydroxylates an asparagine residue in the carboxy-terminal domain of HIF1α. This prevents interaction with the coactivator p300, thereby reducing the transcriptional activity of HIF on promoters bearing a hypoxia response element (HRE). Hydroxylation by prolyl hydroxylase domain (PHD) proteins within the oxygen-dependent degradation (ODD) domain serves as a recognition signal for the ubiquitin ligase VHL, resulting in polyubiquitination and degradation by the 26S proteasome. Hypoxia induces SUMOylation of the ODD by the SUMO-conjugating enzyme Ubc9. Cheng et al. (2007) now report that VHL also recognizes and ubiquitinates SUMOylated HIF1α. However, in the presence of the SUMO-specific isopeptidase SENP1, HIF1α is deSUMOylated, escapes degradation, and activates transcription of various genes involved in erythropoiesis, angiogenesis, and glucose metabolism.
Hydroxylation at an asparagine residue by another dioxygenase prevents interaction with the coactivator p300, thus reducing HIF1α's transcriptional activity. Hypoxia inhibits the hydroxylases, thereby stabilizing HIF1α in an active state (Figure 1) .
Previous reports have implicated the SUMO system in hypoxia. Expression of SUMO is upregulated, and the modifier directly targets HIF1α in response to low oxygen levels (Shao et al., 2004) . Cheng et al. have now identified SENP1 as the SUMOspecific isopeptidase that is responsible for the removal of SUMO from HIF1α. They show that deletion of the SENP1 gene in mice results in early embryonic lethality caused by severe anemia due to lack of HIFdependent erythropoietin production. Thus, deSUMOylation appears to be necessary for HIF1α activity and/or stability. Indeed, the authors found that wild-type HIF1α was rapidly degraded in mouse embryonic fibroblasts lacking SENP1 even in hypoxic conditions, whereas overexpression of SENP1 markedly enhanced HIF1α activity. In contrast, mutant HIF1α that could not be SUMOylated was more stable and much less affected by the presence or absence of the isopeptidase. Upon inhibition of the proteasome, SUMOylated HIF1α accumulated in cells lacking SENP1 during hypoxia, prompting the authors to examine whether SUMOylation might serve as a signal for HIF1α ubiquitination. Consistent with this model, ubiquitinated HIF1α was detected following over expression of SUMO, whereas over expression of the isopeptidase reduced its ubiquitination. Intriguingly, the VHL complex, responsible for ubiquitination of prolyl-hydroxylated HIF1α under physiological oxygen levels, was found to mediate the ubiquitination of sumoylated HIF1α as well. In fact, Cheng et al. were able to demonstrate a direct interaction of the β domain of VHL, which acts as a substratebinding region, with the SUMOylated but not the unmodified forms of HIF1α. Based on these findings, the authors propose that SUMOylation of HIF1α serves as a direct signal for its ubiquitin-dependent degradation.
The notion that SUMO acts as a recognition signal for a ubiquitin ligase is not without precedent. A number of recent publications have reported that the yeast RING finger protein Slx8 and its mammalian homolog RNF4 mediate ubiquitination of proteins in a SUMO-dependent manner (Prudden et al., 2007; Sun et al., 2007; Uzunova et al., 2007; Xie et al., 2007) . Whereas Slx8 in budding and fission yeast dimerizes with a second RING finger protein harboring a SUMO interaction motif that is responsible for recognition of the SUMO moiety, mammalian RNF4 combines both properties in a single polypeptide. Taken together, these reports strongly suggest that in addition to acting in opposition, ubiquitin and SUMO may sometimes cooperate toward a common goal.
In the context of hypoxia, many important questions regarding the function of SUMOylation and deSUMOylation remain unanswered. The findings described here (Figure 1 ) stand in contrast to previous studies implicating SUMO in the activation of transcription through HIF1α stabilization (Bae et al., 2004; CarbiaNagashima et al., 2007) . Indeed, Carbia-Nagashima et al. (2007) recently described in Cell a new hypoxia-induced protein, RSUME, whose overexpression enhances SUMO conjugation and has a stabilizing effect on HIF1α. According to this report, RSUME promotes SUMOylation by enhancing its activation via thioester formation, but it also interacts with several known SUMO substrates such as IκBα and HIF1α, suggesting that it is directly involved in the conjugation reaction. Yet another study reported that hypoxia-induced SUMOylation of HIF1α reduces its transcriptional activity without affecting its half-life (Berta et al., 2007) .
In their new work, Cheng et al. have convincingly shown that the deSUMOylating activity of SENP1 is required for HIF-dependent transcription during embryogenesis; however, their model invoking SENP1-mediated stabilization of HIF1α does not explain how or why the protein is subject to hypoxia-induced SUMOylation at all. A requirement for consecutive SUMOylation and deSUMOylation events would solve this puzzle if SUMO conjugation were involved in the translocation of HIF1α into the nucleus; however, the authors claim that this is not the case. It also remains to be determined how VHL recognizes the SUMOylated form of HIF1α when it normally binds to the hydroxylated form. Finally, it appears as if additional modifications, such as acetylation and phosphorylation, and other ubiquitin ligases may also influence the activity and stability of HIF1α . These notions suggest that multiple regulatory pathways converge to control key modulators of cellular metabolism, such as HIF1α, and much additional work will be required to elucidate their mechanisms and interdependencies.
